MassARRAY System– highly accurate, sensitive analysis for Cancer Research
Sequenom offers a broad portfolio of solutions for cancer research from DNA methylation and gene expression, to somatic mutation and copy number analysis. At the heart is the MassARRAY® system, based on MALDI-TOF mass spectrometry. It enables highly accurate, sensitive, and high-throughput methods pivotal to cancer research.
Applications for Cancer Research
Genotyping & Copy Number
Somatic mutation profiling
Product Spotlight for Cancer Mutation Profiling
Sequenom now offers a growing number of cancer research panels for somatic mutation profiling. Use Assay Explorer™ to search through the OncoCarta™ Panel family.
OncoCarta™ v1.0—the first research panel
for comprehensive oncogene analysis with 238 mutations and 19 genes
OncoCarta™ v2.0—an extended research panel for investigation of tyrosine kinase and cell signaling pathways such as CTNNB1 and MAP2K with 166 mutations and 18 genes
OncoCarta™ v3.0—a research panel with 105 mutations from 22 oncogenes and a number of tumor suppressors including PTEN, p53 and RB1
MelaCarta™ v1.0—a targeted research panel for melanoma cancer screening with 72 mutations and 20 genes
For more information, view our OncoCarta™ Webinar
or view the MassARRAY® for Cancer Analysis Brochure
Recent Publications in the News
Search our Publication database by cancer disease, gene, or author to access the latest peer-reviewed publications using the MassARRAY® system for cancer research.
Note: The MassARRAY Analyzer 4 system, OncoCarta, LungCarta, iPLEX Gold, iSEQ, QGE, EpiTYPER, TYPER software, iPLEX ADME PGx panel, iPLEX ID Panel, Assay Explorer and MelaCarta are for Research Use Only. Not for Use in Diagnostic Procedures.